RegWardenFDA facility compliance records
Facility

Senseonics, Inc.

1 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2017: 1 inspections; 2019: 1 recalls; 2023: 1 inspections1201720181201920202021202212023202420252026
  • Recalls (1)
  • Inspections (2)

Devices registered here (1)

  • Continuous Glucose Monitor Secondary Display
    Product code PJT (opens in a new tab) · Class II · Clinical Chemistry · 21 CFR 862.1350

Recalls & enforcement

  • Class IITerminated2019-09-18
    Eversense Sensors have prematurely stopped functioning due to inadequate hydration of the sensor s glucose-sensing surface

FDA inspections (2)

  • NAI2023-11-17
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
  • NAI2017-01-31
    No Action Indicated · Bioresearch Monitoring

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Senseonics, Inc. (FEI 3009862700) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3009862700-senseonics-inc/

Not open yet

Alerts for Senseonics, Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.